Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07470957) titled 'A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease' on March 10.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: EMD Serono Research & Development Institute, Inc.
Condition:
Systemic Lupus Erythematosus (SLE)
Cutaneous Lupus Erythematosus (CLE)
Intervention:
Drug: Enpatoran
Drug: Placebo
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: March 27, 2026
Tar...